Laporan Laba Rugi (TTM)
Laporan Laba Rugi Madame Bioscience Public Company Limited - Equity Right menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,488 | 1,517 | 1,540 | 1,645 | 1,711 | 1,862 | 2,068 | 2,194 | 2,255 | 2,228 | 2,180 | 2,217 | 2,209 | 2,302 | 2,244 | 2,149 | 2,152 | 2,123 | 1,940 | 1,754 |
| Change (%) | 1.96 | 1.53 | 6.84 | 3.98 | 8.87 | 11.07 | 6.05 | 2.81 | -1.22 | -2.12 | 1.69 | -0.39 | 4.23 | -2.50 | -4.25 | 0.16 | -1.37 | -8.62 | -9.60 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 1,188 | 1,224 | 1,253 | 1,338 | 1,411 | 1,561 | 1,735 | 1,902 | 1,974 | 2,146 | 2,118 | 2,089 | 2,129 | 2,006 | 1,942 | 1,863 | 1,800 | 1,763 | 1,654 | 1,458 |
| Change (%) | 3.06 | 2.40 | 6.74 | 5.47 | 10.63 | 11.14 | 9.65 | 3.80 | 8.70 | -1.33 | -1.37 | 1.92 | -5.79 | -3.16 | -4.10 | -3.38 | -2.03 | -6.20 | -11.83 | |
| % of Revenue | 79.84 | 80.70 | 81.40 | 81.32 | 82.49 | 83.82 | 83.87 | 86.72 | 87.56 | 96.35 | 97.13 | 94.21 | 96.39 | 87.12 | 86.54 | 86.67 | 83.61 | 83.04 | 85.25 | 83.15 |
| Gross Operating Profit | 300 | 293 | 286 | 307 | 300 | 301 | 334 | 291 | 281 | 81 | 63 | 128 | 80 | 296 | 302 | 286 | 353 | 360 | 286 | 296 |
| Change (%) | -2.41 | -2.13 | 7.26 | -2.49 | 0.58 | 10.71 | -12.67 | -3.69 | -71.02 | -22.99 | 105.15 | -38.00 | 272.15 | 1.94 | -5.22 | 23.20 | 2.03 | -20.51 | 3.28 | |
| % of Revenue | 20.16 | 19.30 | 18.60 | 18.68 | 17.51 | 16.18 | 16.13 | 13.28 | 12.44 | 3.65 | 2.87 | 5.79 | 3.61 | 12.88 | 13.46 | 13.33 | 16.39 | 16.96 | 14.75 | 16.85 |
| SG&A | 329 | 354 | 349 | 358 | 379 | 415 | 436 | 473 | 500 | 511 | 518 | 503 | 478 | 484 | 472 | 444 | 415 | 338 | 396 | 406 |
| Change (%) | 7.52 | -1.51 | 2.53 | 5.85 | 9.64 | 5.06 | 8.49 | 5.72 | 2.26 | 1.25 | -2.83 | -5.05 | 1.34 | -2.44 | -5.91 | -6.52 | -18.65 | 17.15 | 2.54 | |
| % of Revenue | 22.14 | 23.35 | 22.65 | 21.74 | 22.13 | 22.28 | 21.08 | 21.56 | 22.18 | 22.96 | 23.75 | 22.69 | 21.63 | 21.03 | 21.04 | 20.68 | 19.30 | 15.92 | 20.41 | 23.15 |
| R&D | ||||||||||||||||||||
| Change (%) | ||||||||||||||||||||
| % of Revenue | ||||||||||||||||||||
| OpEx | 1,501 | 1,564 | 1,608 | 1,692 | 1,756 | 1,972 | 2,135 | 2,331 | 2,450 | 2,613 | 2,602 | 2,569 | 2,593 | 2,468 | 2,394 | 2,292 | 2,301 | 2,081 | 1,662 | 1,470 |
| Change (%) | 4.18 | 2.85 | 5.22 | 3.77 | 12.32 | 8.24 | 9.18 | 5.11 | 6.66 | -0.43 | -1.26 | 0.93 | -4.80 | -3.02 | -4.27 | 0.43 | -9.57 | -20.13 | -11.54 | |
| % of Revenue | 100.90 | 103.10 | 104.44 | 102.86 | 102.66 | 105.91 | 103.21 | 106.25 | 108.63 | 117.30 | 119.32 | 115.86 | 117.40 | 107.22 | 106.66 | 106.64 | 106.92 | 98.02 | 85.68 | 83.84 |
| Operating Income | -13 | -47 | -68 | -47 | -45 | -110 | -66 | -137 | -195 | -385 | -421 | -352 | -384 | -166 | -149 | -143 | -149 | 42 | 278 | 283 |
| Change (%) | 250.18 | 45.50 | -31.15 | -3.49 | 142.17 | -39.66 | 106.52 | 41.90 | 97.98 | 9.29 | -16.53 | 9.29 | -56.74 | -10.12 | -4.51 | 4.40 | -128.18 | 561.97 | 1.97 | |
| % of Revenue | -0.90 | -3.10 | -4.44 | -2.86 | -2.66 | -5.91 | -3.21 | -6.25 | -8.63 | -17.30 | -19.32 | -15.86 | -17.40 | -7.22 | -6.66 | -6.64 | -6.92 | 1.98 | 14.32 | 16.16 |
| Interest Expense | -8 | -9 | -9 | -11 | -12 | -11 | -14 | -21 | -29 | -42 | -51 | -56 | -60 | -61 | -60 | -58 | -55 | -51 | -47 | -43 |
| Change (%) | 8.51 | 4.84 | 12.21 | 9.03 | -8.18 | 34.32 | 49.80 | 37.70 | 43.94 | 21.65 | 10.23 | 6.20 | 1.86 | -1.36 | -4.46 | -4.40 | -7.48 | -7.75 | -9.41 | |
| % of Revenue | -0.56 | -0.59 | -0.61 | -0.64 | -0.67 | -0.57 | -0.69 | -0.97 | -1.30 | -1.89 | -2.35 | -2.55 | -2.72 | -2.65 | -2.69 | -2.68 | -2.56 | -2.40 | -2.42 | -2.43 |
| Net Income | -38 | -59 | -58 | -40 | -31 | -152 | -129 | -199 | -253 | -422 | -463 | -400 | -450 | -406 | -392 | -384 | -388 | -332 | -95 | -86 |
| Change (%) | 54.01 | -1.48 | -31.13 | -21.28 | 386.11 | -15.61 | 54.44 | 27.37 | 66.90 | 9.61 | -13.53 | 12.55 | -9.91 | -3.52 | -1.90 | 0.95 | -14.36 | -71.53 | -8.84 | |
| % of Revenue | -2.56 | -3.87 | -3.76 | -2.42 | -1.83 | -8.19 | -6.22 | -9.06 | -11.22 | -18.96 | -21.23 | -18.05 | -20.40 | -17.63 | -17.44 | -17.87 | -18.01 | -15.64 | -4.87 | -4.91 |
Source: Capital IQ
